Diversifying Eligibility to Enhance Real-World Results

被引：0
|
作者：
Fayyaz, Fatima [1 ]
Carvajal, Richard D. [1 ]
Devoe, Craig E. [1 ,2 ]
机构：
[1] Northwell Hlth Canc Inst, Lake Suceess, NY USA
[2] Zuckerberg Canc Ctr, 450 Lakeville Rd, Lake Success, NY 11042 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 23期
关键词：
NIVOLUMAB PLUS IPILIMUMAB; MELANOMA PATIENTS; OPEN-LABEL; MULTICENTER; COMBINATION; TRIAL;
D O I：
10.1200/JCO.23.00836
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3895 / +
页数：5
相关论文
共 50 条
  • [21] Identifying candidates for real-world peanut oral immunotherapy: eligibility and barriers to participation
    Blackman, A.
    Anagnostou, A.
    ALLERGY, 2021, 76 : 353 - 353
  • [22] MAPPING REAL-WORLD ANKYLOSINC SPONDYLITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA
    Sholter, Dalton
    Inman, Robert
    Masetto, Ariel
    Rahman, Proton
    Rampakakis, Emmanouil
    Asin-Milan, Odalis
    Rachich, Meagan
    Nantel, Francois
    Lehman, Allen J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 26 - 27
  • [23] Mapping Real-World Ankylosing Spondylitis Patients to Clinical Trial Eligibility Criteria
    Sholter, Dalton
    Inman, Robert
    Masetto, Ariel
    Rahman, Proton
    Rampakakis, Emmanouil
    Asin-Milan, Odalis
    Rachich, Meagan
    Nantel, Francois
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1101 - 1101
  • [24] Mapping Real-World Psoriatic Arthritis Patients to Clinical Trial Eligibility Criteria
    Arendse, Regan
    Haaland, Derek
    Fortin, Isabelle
    Rahman, Proton
    Rampakakis, Emmanouil
    Asin-Milan, Odalis
    Rachich, Meagan
    Nantel, Francois
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1035 - 1036
  • [25] Mapping Real-World Rheumatoid Arthritis Patients to Clinical Trial Eligibility Criteria
    Keystone, Edward
    Olszynski, Wojciech
    Bessette, Louis
    Rahman, Proton
    Rampakakis, Emmanouil
    Lehman, Allen
    Asin-Milan, Odalis
    Nantel, Francois
    Rachich, Meagan
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1107 - 1108
  • [26] Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort
    von Lewinski, Dirk
    Herold, Lukas
    Bachl, Eva
    Bugger, Heiko
    Glantschnig, Theresa
    Kolesnik, Ewald
    Verheyen, Nicolas
    Benedikt, Martin
    Wallner, Markus
    von Lewinski, Friederike
    Schmidt, Albrecht
    Harb, Stefan
    Ablasser, Klemens
    Sacherer, Michael
    Scherr, Daniel
    Manninger-Wuenscher, Martin
    Paetzold, Sascha
    Gollmer, Johannes
    Zirlik, Andreas
    Toth, Gabor G.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [27] Missing data in the eligibility criteria of synthetic controls from real-world data
    Li, Liang
    Jemielita, Thomas
    Chen, Cong
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2025,
  • [28] Evaluating eligibility criteria of oncology trials using real-world data and AI
    Ruishan Liu
    Shemra Rizzo
    Samuel Whipple
    Navdeep Pal
    Arturo Lopez Pineda
    Michael Lu
    Brandon Arnieri
    Ying Lu
    William Capra
    Ryan Copping
    James Zou
    Nature, 2021, 592 : 629 - 633
  • [29] Real-world patient eligibility for lurbinectedin/doxorubicin in small cell lung cancer
    Rittberg, R.
    Leung, B.
    Al-Hashami, Z.
    Ho, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S101 - S102
  • [30] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
12345